Carcinoma in Situ
📧 Sign up to get email alerts when something new happens for Carcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose. [Phase 4]
A Phase 4 trial evaluating reinduction with Nadofaragene firadenovec in bladder cancer patients with CIS ± high-grade Ta/T1 and no complete …